Table 2 NSCLC case study: Drugs, left column, and their corresponding targets, right column, related to the proposed case study
From: MiRNA therapeutics based on logic circuits of biological pathways
Drug | Target |
|---|---|
Osimertinib | EGFR |
Alectinib | ALK |
Dabrafenib | BRAF |
Trametinib | BRAF,MEK |
Everolimus | AKT |
BKM120 | PI3K |